http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2058817-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c7d3363b51098ef3851674877dcf031 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 |
| filingDate | 1992-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b15d74447f1d452254421729d714e53 |
| publicationDate | 1993-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2058817-A1 |
| titleOfInvention | Pharmaceutical preparation for topical application |
| abstract | A B S T R A C T Pharmaceutical preparations containing 1 to 10 % by weight L-lysine salt of the 2-[(3-chloro-2-methylphenyl)amino]-3-pyridine carboxylic acid as active substance, 2 to 15 % by weight pharmaceutically acceptable emulsifiers, 2 to 20 % by weight pharmaceutically acceptable emollients, 0.01 to 0.2 % by weight pharmaceutically acceptable preservation substances and the remainder water made up to 100 % by weight, and possibly 0.2 to 5 % by weight rubefacients, the water being correspondingly adjusted to a total of 100 % by weight, are suitable for topical application to relieve/alleviate pain and/or inflammation in humans and animals. |
| priorityDate | 1992-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.